Gara Jalqabaatti › Oligodendroglioma
Qorannoo klinikaalii Oligodendroglioma Ameerikaa Keessatti hirmaatuu
Qorannoo 15 Oligodendroglioma f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 4
- St. Louis, MOQorannoo 3
- Miami, FLQorannoo 3
- Boston, MAQorannoo 3
- Philadelphia, PAQorannoo 3
Naannoon
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 19 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05698524SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 2 hanga 24 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT04923126FearLess in NeuroOncology
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06989086HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Namoota walitti qabaa jiraSadarkaa 1
36 Months – 22 Years · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT03911388Study of Olutasidenib and Temozolomide in HGG
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 hanga 39 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05303519Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ado-2026 · NCT04623931Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Wax-2026 · NCT07468136ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 89 · Saalaa hunda · Haaromfame 27-Cam-2026 · NCT06254326Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Elb-2026 · NCT07462507All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Gur-2026 · NCT05345002Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Mud-2025 · NCT04541082Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 08-Mud-2025 · NCT05956821HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Sad-2025 · NCT06930846Implantable Microdevice In Primary Brain Tumors
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ado-2025 · NCT04135807Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.